Advertisement

Topics

Roche S.A.Q Company Profile

03:19 EDT 20th September 2018 | BioPortfolio

Nil

Contact

Email: farmacovigilancia@roche.com.ar


News Articles [947 Associated News Articles listed on BioPortfolio]

Roche-GS im Plus: Roche übernimmt Foundation Medicine ganz

Im Zuge der Vereinbarung wird Roche die noch ausstehenden Anteile an dem in der Krebsforschung tätigen US-Unternehmens für 137 US-Dollar je Aktie in bar übernehmen. Insgesamt werde Roche somit 2,4 ...

Roche: What they look for in a partner

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Dan Zabrowski, Global Head of Pharma Partnering at Roche. Filmed at BIO-Europe 2009, they discuss: • what Roche is currently...

Changes to the Roche Enlarged Corporate Executive Committee

Roche today announced that John C. Reed (1958), MD, PhD, Head of Roche Pharma Research and Early Development (pRED) since 2013, has decided to leave Roche for personal reasons and will return to the U...

Roche: Partnering and Global Activity

In this episode of PharmaTelevision News Review, Fintan Walton talks with Bardia Akbari, Global Head of Partnering, Inflammation and AutoImmune at Hoffmann-La Roche. Filmed at AusBiotech 2009, they di...

Roche, Dan Zabrowski talks about changes in the industry as Roche celebrates 10 years of Roche Pharma Partnering

In this episode of PharmaTelevision News Review, filmed at BIO 2011, Fintan Walton talks to Dan Zabrowski, Head of Partnering at Roche.

Roche Agrees to Pay $2.4 Billion to Acquire the Rest of Foundation Medicine

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Foundation Medicine, Inc. (NASDAQ: FMI) today announced they have entered into a definitive merger agreement for Roche to acquire the outstanding shares of FMI...

Roche will Merck bei neuem Feld für Krebs-Therapie abhängen: Der Schweizer Pharmakonzern Roche droht ...

Der Schweizer Pharmakonzern Roche droht in der Branche abgehängt zu werden. Ein Durchbruch müsste her. Zum Beispiel in der Krebsforschung.Der Pharmakonzern Roche weigert sich, den heißesten neuen B...

Reinventing Roche’s Pipeline

Despite the current economic climate, Roche’s fundamental strategy has remained the same and, as with many major pharmaceutical companies, their focus is still their pipeline. Andrew Jefferson, inte...

Drugs and Medications [18 Associated Drugs and Medications listed on BioPortfolio]

Targretin [Eisai Inc.]

Targretin® (bexarotene) capsules, 75 mg

Toradol oral(ketorolac tromethamine tablets) [Hoffmann-La Roche Inc.]

TORADOL ORAL(ketorolac tromethamine tablets)

Fansidarbrand ofsulfadoxine and pyrimethaminetablets [Roche Pharmaceuticals]

FANSIDARbrand ofsulfadoxine and pyrimethamineTABLETS

Acular ls [Physicians Total Care, Inc.]

Valium [Cardinal Health]

VALIUM CIV brand of diazepam TABLETS

PubMed Articles [27 Associated PubMed Articles listed on BioPortfolio]

Field evaluation of GeneXpert (Cepheid) HCV performance for RNA quantification in a Genotype 1 and 6 predominant patient population in Cambodia.

GeneXpert (Cepheid) is the only WHO prequalified platform for Hepatitis C Virus (HCV) Nucleic Acid Amplification Testing that is suitable for point-of-care use in resource-limited contexts. However, i...

Evaluation of BD Vacutainer® Barricor™ blood collection tubes for routine chemistry testing on a Roche Cobas® 8000 Platform.

Barricor™ Vacutainers® are a novel non-gel separator blood collection tube. These tubes enable faster pre-analytical processing which could reduce turnaround time and be beneficial in an acute care...

Measurement Differences Between Two Immunoassay Systems for LH and FSH: A Comparison of Roche Cobas e601 vs. Abbott Architect i2000sr.

Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) regulate the growth and reproductive activity of gonadal tissue and determine the concentration of LH is essential for the prediction of...

Roche splashes $2.4 billion on Foundation Medicine's cancer platform.

Roche pays $1.9 billion for Flatiron's army of electronic health record curators.

Clinical Trials [52 Associated Clinical Trials listed on BioPortfolio]

This is an Extension Study of the Roche P-trial to Investigate Safety and Effectiveness of a Single Ocrelizumab Dose in Participants With Multiple Sclerosis (MS)

This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who were previously enrolled in a F. Hoffmann-La Roche (Roche) sponso...

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols.

This single arm study will provide treatment or re-treatment with PEGASYS as monotherapy or in combination with ribavirin (Copegus), to patients with chronic hepatitis C (CHC) who have par...

Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients

Traumatic coagulopathy is frequent and is an independent risk factor of mortality. Its detection mainly relies upon classic biological test like the prothrombin time and the international ...

Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in De Novo Adult Renal Transplant Recipients

This study will evaluate the safety and efficacy of FTY720 versus mycophenolate mofetil (MMF, Roche brand) combined with cyclosporine and corticosteroids in patients receiving a kidney tra...

A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Oseltamivir from Oseltamivir 75 mg capsules (Pharmacare PLC, Palestine) and Tami...

Companies [86 Associated Companies listed on BioPortfolio]

Roche Diagnostics, Inc.

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with trul...

Roche Diagnostics GmbH

Nil

Roche NimbleGen

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest...

Roche Group

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest...

Roche Applied Science

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest...

More Information about "Roche S.A.Q" on BioPortfolio

We have published hundreds of Roche S.A.Q news stories on BioPortfolio along with dozens of Roche S.A.Q Clinical Trials and PubMed Articles about Roche S.A.Q for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Roche S.A.Q Companies in our database. You can also find out about relevant Roche S.A.Q Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record